1FDA. FDA Drug Safety Communication:ongoing safety review of Parkinson's drug Mirapex (pramipexole) and possible risk of heart failure[EB/OL].http://www.fda.gov/Drugs/DrugSafety/ucm319779.htm,2012.
2Renoux C,Dell'Aniello S,Brophy JM. Dopamine agonist use and the risk of heart failure[J].Pharmacoepidemiology and Drug Safety,2012,(01):34-41.
3Mokhles MM,Trifirò G,Dieleman JP. The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease[J].Pharmacological Research,2012,(03):358-364.
